Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Stefano D'ardia"'
Autor:
Federica Catania, Chiara Frairia, Matteo Olivi, Moreno Festuccia, Davide Rapezzi, Barbara Nicolino, Giulia Arrigo, Eleonora Boscaro, Federica DI Biase, Marco Cerrano, Irene Urbino, Eloise Beggiato, Giuseppe Lanzarone, Chiara Maria Dellacasa, Alessandro Busca, Dario Ferrero, Stefano D’ardia, Ernesta Audisio, Roberto Freilone, Valentina Giai
Publikováno v:
HemaSphere, Vol 7, p e214549f (2023)
Externí odkaz:
https://doaj.org/article/dfea8515cb74466aa5dd64b0b6da2687
Autor:
Irene Urbino, Chiara Frairia, Alessandro Busca, Silvia Corcione, Stefano D'Ardia, Chiara Maria Dellacasa, Valentina Giai, Carolina Secreto, Roberto Freilone, Francesco Giuseppe De Rosa, Semra Aydin, Giovannino Ciccone, Rosalba Rosato, Marco Cerrano, Ernesta Audisio
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 15, Iss 1 (2023)
Background and objectives: acute myeloid leukemia (AML) patients are at high risk of infections during post induction neutropenia. Recently, the role of antibacterial prophylaxis has been reconsidered due to concerns about the emergence of multi-resi
Externí odkaz:
https://doaj.org/article/d0581b4b379640d0a9a8451bf09c3429
Autor:
Yuliya Yakymiv, Stefania Augeri, Cristiano Bracci, Sara Marchisio, Semra Aydin, Stefano D’Ardia, Massimo Massaia, Enza Ferrero, Erika Ortolan, Ada Funaro
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
Abstract CD157/BST-1 (a member of the ADP-ribosyl cyclase family) is expressed at variable levels in 97% of patients with acute myeloid leukemia (AML), and is currently under investigation as a target for antibody-based immunotherapy. We used periphe
Externí odkaz:
https://doaj.org/article/e9e93bf36a764005b7551cdd3f88294d
Autor:
Semra Aydin, Valentina Giai, Stefano D'ardia, Giorgia Iovino, Chiara Frairia, Irene Urbino, Marco Cerrano, Eloise Beggiato, Ernesta Audisio
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S37- (2022)
Objective: Paroxysmal nocturnal hemoglobinuria (PNH) has always been considered a relative contraindication for pregnancy. The use of eculizumab has reduced morbidity and mortality of fetus and mother. Dose adjustments are often required due to emerg
Externí odkaz:
https://doaj.org/article/836e78707b4b4ccb8d35de130b1b764a
Autor:
Hartmut Döhner, Argiris Symeonidis, Dries Deeren, Judit Demeter, Miguel A. Sanz, Achilles Anagnostopoulos, Jordi Esteve, Walter Fiedler, Kimmo Porkka, Hee-Je Kim, Je-Hwan Lee, Kensuke Usuki, Stefano D'Ardia, Chul Won Jung, Olga Salamero, Heinz-August Horst, Christian Recher, Philippe Rousselot, Irwindeep Sandhu, Koen Theunissen, Felicitas Thol, Konstanze Döhner, Veronica Teleanu, Daniel J. DeAngelo, Tomoki Naoe, Mikkael A. Sekeres, Valerie Belsack, Miaomiao Ge, Tillmann Taube, Oliver G. Ottmann
Publikováno v:
HemaSphere, Vol 5, Iss 8, p e617 (2021)
In this phase 3 trial, older patients with acute myeloid leukemia ineligible for intensive chemotherapy were randomized 2:1 to receive the polo-like kinase inhibitor, volasertib (V; 350 mg intravenous on days 1 and 15 in 4-wk cycles), combined with l
Externí odkaz:
https://doaj.org/article/f447c1cf31de4bcc96ad51294c483c91
Autor:
Federica Martella, Marco Cerrano, Daniela Di Cuonzo, Carolina Secreto, Matteo Olivi, Vincenzo Apolito, Stefano D’Ardia, Chiara Frairia, Valentina Giai, Giuseppe Lanzarone, Irene Urbino, Roberto Freilone, Luisa Giaccone, Alessandro Busca, Chiara Maria Dellacasa, Ernesta Audisio, Dario Ferrero, Eloise Beggiato
Publikováno v:
Annals of Hematology. 101:855-867
The frequency of thrombosis in AML has been evaluated only in a few studies and no validated predictive model is currently available. Recently, DIC score was shown to identify patients at higher thrombotic risk. We aimed to evaluate the frequency of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d42a3367966ab96ce25ef4b0f1bc24fb
https://doi.org/10.1007/s00277-022-04770-6
https://doi.org/10.1007/s00277-022-04770-6
Autor:
Semra Aydin, Roberto Passera, Marco Cerrano, Valentina Giai, Stefano D’Ardia, Giorgia Iovino, Chiara Maria Dellacasa, Ernesta Audisio, Alessandro Busca
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1002
Volume 15
Issue 4
Pages: 1002
Background: Accurate assessment of elderly acute myeloid leukemia (AML) patients is essential before intensive induction chemotherapy and subsequent allogeneic hematopoietic stem cell transplantation. In this context, we investigated the capacity of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e4a60d89ca0d09046861bb457d6cc4f
Autor:
Francesco Autore, Eros Di Bona, Stefano D'Ardia, Paola Carluccio, Fabio Efficace, Walter Fiedler, Nicola Stefano Fracchiolla, Richard F. Schlenk, Monica Fumagalli, Karin Mayer, Valentina Mancini, G. Beltrami, Paola Fazi, Erika Borlenghi, Massimo Bernardi, Uwe Platzbecker, Massimo Breccia, Marco Vignetti, Prassede Salutari, Olimpia Finizio, Francesco Cottone, Luciano Levato, Ombretta Annibali, Lorella Melillo, Maria Teresa Voso
Publikováno v:
Blood Advances
Key Points Patients with APL treated with ATRA-ATO reported better long-term quality of life outcomes than patients treated with chemotherapy.Late comorbidity and health problem prevalence was similar between patients with APL previously treated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4f9e40914e95f56e37df944f2ddb06a
https://doi.org/10.1182/bloodadvances.2021004649
https://doi.org/10.1182/bloodadvances.2021004649
Autor:
Carolina Terragna, Maria Paola Martelli, Paolo de Fabritiis, Anna Candoni, Alessandra Tedeschi, Giovanni Martinelli, Monia Lunghi, Stefania Paolini, Michele Baccarani, Alfonso Piciocchi, Francesco Fabbiano, Luca Frison, Monica Bocchia, Antonella Vitale, Antonella Fornaro, Cristina Papayannidis, Antonio Cuneo, Piero Galieni, Muriel Granier, Mingyue Wang, Michele Cavo, Robin Foà, Paola Fazi, Marco Vignetti, Chiara Sartor, Roberto M. Lemoli, Fabio Guolo, Simona Soverini, Carmine Selleri, Mariachiara Abbenante, Valentina Robustelli, Giovanni Marconi, Federico Simonetti, Silvia Trappolini, Massimiliano Bonifacio, Patrizia Tosi, Stefano D'Ardia, Zhaoyin Zhu
Tyrosine kinase inhibitors have improved survival for patients with Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL). However, prognosis for old or unfit patients remains poor. In the INCB84344-201 (formerly GIMEMA LAL 1811
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::532a7ef6c6f327838c21185db5ce9234
http://hdl.handle.net/11567/1078678
http://hdl.handle.net/11567/1078678
Autor:
Philippe Rousselot, Veronica Teleanu, Kimmo Porkka, Christian Recher, Achilles Anagnostopoulos, Oliver G. Ottmann, Miguel A. Sanz, Daniel J. DeAngelo, Mikkael A. Sekeres, Felicitas Thol, Hartmut Döhner, Kensuke Usuki, Konstanze Döhner, Dries Deeren, Miaomiao Ge, Stefano D'Ardia, Olga Salamero, Irwindeep Sandhu, Chul Won Jung, Tillmann Taube, Je-Hwan Lee, Tomoki Naoe, Koen Theunissen, Jordi Esteve, Heinz-August Horst, Judit Demeter, Walter Fiedler, Valerie Belsack, Argiris Symeonidis, Hee-Je Kim
Publikováno v:
HemaSphere, Vol 5, Iss 8, p e617 (2021)
HemaSphere
Scientia
HemaSphere
Scientia
Terapia de inducción estándar; Volasertib adyuvante; Leucemia mieloide aguda Standard Induction Therapy; Adjunctive Volasertib; Acute Myeloid Leukemia Teràpia d'inducció estàndard; Volasertib adjuvant; Leucèmia mieloide aguda In this phase 3 tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d3eceaa0a4b7e82f485141bcfd03e6e
http://journals.lww.com/10.1097/HS9.0000000000000617
http://journals.lww.com/10.1097/HS9.0000000000000617